1-6 of 6
Amit Roy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors

Yue Zhao, Zheyi Hu, Sai Praneeth Bathena, Sarah Keidel, Karen Miller-Moslin, Paul Statkevich, Akintunde Bello, Amit Roy, Satyendra Suryawanshi
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (14): 3050–3058.
https://doi.org/10.1158/1078-0432.CCR-23-2396
Published: 15 July 2024
View article titled, Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors
Open the PDF for Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Exposure–Response Analysis to Support Nivolumab Once Every 4 Weeks Dosing in Combination with Cabozantinib in Renal Cell Carcinoma

Lora Hamuro, Zheyi Hu, Julie Passarell, Heather Barcomb, Joshua Zhang, Shay Goldstein, Akintunde Bello, Amit Roy, Li Zhu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1603–1613.
https://doi.org/10.1158/1078-0432.CCR-21-3149
Published: 14 April 2022
View article titled, Exposure–Response Analysis to Support Nivolumab Once Every 4 Weeks Dosing in Combination with Cabozantinib in Renal Cell Carcinoma
Open the PDF for Exposure–Response Analysis to Support Nivolumab Once Every 4 Weeks Dosing in Combination with Cabozantinib in Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Identification of Non–Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics

Laurent Dercle, Matthew Fronheiser, Lin Lu, Shuyan Du, Wendy Hayes, David K. Leung, Amit Roy, Julia Wilkerson, Pingzhen Guo, Antonio T. Fojo, Lawrence H. Schwartz, Binsheng Zhao
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (9): 2151–2162.
https://doi.org/10.1158/1078-0432.CCR-19-2942
Published: 01 May 2020
View article titled, Identification of Non–Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics
Open the PDF for Identification of Non–Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics in another window
Includes: Supplementary data
Journal Articles

Nivolumab Exposure–Response Analyses of Efficacy and Safety in Previously Treated Squamous or Nonsquamous Non–Small Cell Lung Cancer

Yan Feng, Xiaoning Wang, Gaurav Bajaj, Shruti Agrawal, Akintunde Bello, Brian Lestini, Friedrich Graf Finckenstein, Jong-Soon Park, Amit Roy
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (18): 5394–5405.
https://doi.org/10.1158/1078-0432.CCR-16-2842
Published: 14 September 2017
View article titled, Nivolumab Exposure–Response Analyses of Efficacy and Safety in Previously Treated Squamous or Nonsquamous Non–Small Cell Lung Cancer
Open the PDF for Nivolumab Exposure–Response Analyses of Efficacy and Safety in Previously Treated Squamous or Nonsquamous Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted Therapy

Lei Nie, Eric H. Rubin, Nitin Mehrotra, José Pinheiro, Laura L. Fernandes, Amit Roy, Stuart Bailey, Dinesh P. de Alwis
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (11): 2623–2629.
https://doi.org/10.1158/1078-0432.CCR-15-2644
Published: 31 May 2016
View article titled, Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted Therapy
Open the PDF for Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted Therapy in another window
Journal Articles

Exposure–Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma

Yan Feng, Amit Roy, Eric Masson, Tai-Tsang Chen, Rachel Humphrey, Jeffrey S. Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (14): 3977–3986.
https://doi.org/10.1158/1078-0432.CCR-12-3243
Published: 15 July 2013
View article titled, Exposure–Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma
Open the PDF for Exposure–Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma in another window
Includes: Supplementary data